Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway.
Clin J Am Soc Nephrol. 2012 Oct;7(10):1591-7. doi: 10.2215/CJN.02150212. Epub 2012 Jul 26.
Skepticism about performing renal biopsies is often because of uncertainty regarding risk of complications. The aim of this study was to evaluate safety and relevant complications of renal biopsies in pediatric and adult patients in a large national registry study.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Kidney biopsies reported in the Norwegian Kidney Biopsy Registry from 1988 to 2010 were included. Risk factors for major complications (blood transfusion and/or surgical or catheter intervention) were analyzed using logistic regression statistics.
Of the 9288 biopsies included, 715 were from children, and 8573 were from adults (≥18 years). Median age was 49 years (range=2 weeks to 94 years). Gross hematuria appeared after biopsy in 1.9% of the patients; 0.9% of patients needed blood transfusion, and 0.2% of patients needed surgical intervention/catheterization. The frequencies were 1.9%, 0.9%, and 0.2% in adults and 1.7%, 0.1% and 0.1% in children, respectively; 97.9% of the biopsies were without complications. In unadjusted analyses, risk factors for major complications were age>60 years, estimated GFR<60 ml/min per 1.73 m(2), systolic hypertension, acute renal failure, and smaller clinical center size (<30 biopsies/yr). Adjusted analyses (adjusted for age and/or estimated GFR) showed higher odds ratios (OR) only for smaller clinical center (OR=1.60 [1.02-2.50]) and low estimated GFR (estimated GFR=30-59 ml/min per 1.73 m(2) [OR=4.90 (1.60-14.00)] and estimated GFR<30 ml/min per 1.73 m(2) [OR 15.50 (5.60-43.00)]).
Percutaneous renal biopsy is a low-risk procedure in all ages. Reduced estimated GFR and smaller center size are associated with an increased risk of major complications.
对进行肾活检的怀疑通常是因为对并发症风险的不确定性。本研究的目的是在一个大型国家注册研究中评估儿童和成人患者肾活检的安全性和相关并发症。
设计、设置、参与者和测量:纳入了 1988 年至 2010 年在挪威肾活检登记处报告的肾活检。使用逻辑回归统计分析了主要并发症(输血和/或手术或导管介入)的危险因素。
在纳入的 9288 例活检中,715 例来自儿童,8573 例来自成人(≥18 岁)。中位年龄为 49 岁(范围=2 周至 94 岁)。活检后有 1.9%的患者出现肉眼血尿;0.9%的患者需要输血,0.2%的患者需要手术干预/置管。成人的频率分别为 1.9%、0.9%和 0.2%,儿童的频率分别为 1.7%、0.1%和 0.1%;97.9%的活检无并发症。在未调整的分析中,主要并发症的危险因素是年龄>60 岁、估计肾小球滤过率(GFR)<60 ml/min/1.73 m(2)、收缩压升高、急性肾衰竭和较小的临床中心规模(<30 例/年)。调整分析(按年龄和/或估计 GFR 调整)仅显示较小的临床中心(比值比[OR]=1.60[1.02-2.50])和低估计 GFR(估计 GFR=30-59 ml/min/1.73 m(2) [OR=4.90(1.60-14.00)]和估计 GFR<30 ml/min/1.73 m(2) [OR 15.50(5.60-43.00)])的比值比更高。
经皮肾活检在所有年龄段都是一种低风险的操作。估计肾小球滤过率降低和中心规模较小与主要并发症风险增加相关。